These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37951480)

  • 1. Acute kidney injury associated with colistin sulfate vs. polymyxin B sulfate therapy: A real-world, retrospective cohort study.
    Zhang Y; Dong R; Huang Y; Ling X; Ye Z; Jiang S
    Int J Antimicrob Agents; 2024 Jan; 63(1):107031. PubMed ID: 37951480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for acute kidney injury in patients treated with polymyxin B or colistin methanesulfonate sodium.
    Tuon FF; Rigatto MH; Lopes CK; Kamei LK; Rocha JL; Zavascki AP
    Int J Antimicrob Agents; 2014 Apr; 43(4):349-52. PubMed ID: 24439066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for acute kidney injury (AKI) in patients treated with polymyxin B and influence of AKI on mortality: a multicentre prospective cohort study.
    Rigatto MH; Behle TF; Falci DR; Freitas T; Lopes NT; Nunes M; Costa LW; Zavascki AP
    J Antimicrob Chemother; 2015 May; 70(5):1552-7. PubMed ID: 25604744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicenter Prospective Cohort Study of Renal Failure in Patients Treated with Colistin versus Polymyxin B.
    Rigatto MH; Oliveira MS; Perdigão-Neto LV; Levin AS; Carrilho CM; Tanita MT; Tuon FF; Cardoso DE; Lopes NT; Falci DR; Zavascki AP
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2443-9. PubMed ID: 26856846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nephrotoxicity in Patients with or without Cystic Fibrosis Treated with Polymyxin B Compared to Colistin.
    Crass RL; Rutter WC; Burgess DR; Martin CA; Burgess DS
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colistin versus polymyxin B: A pragmatic assessment of renal and neurological adverse effects and effectiveness in multidrug-resistant Gram-negative bacterial infections.
    Simon V; Viswam A; Alexander PS; James E; Sudhindran S
    Indian J Pharmacol; 2023; 55(4):229-236. PubMed ID: 37737075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of polymyxin-B-associated acute kidney injury in 1-year mortality and renal function recovery.
    Gomes EC; Falci DR; Bergo P; Zavascki AP; Rigatto MH
    Int J Antimicrob Agents; 2018 Jul; 52(1):86-89. PubMed ID: 29501603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of polymyxin B-induced acute kidney injury with a non adjusted dose versus adjusted dose based on renal function.
    Zheng G; Cai J; Zhou S; Du N; Bai H; He J; Bian X
    Per Med; 2022 Jul; 19(4):307-314. PubMed ID: 35762314
    [No Abstract]   [Full Text] [Related]  

  • 9. Comment on 'Acute kidney injury associated with colistin sulfate vs. polymyxin B sulfate therapy: A real-world, retrospective cohort study'.
    Zhang CJ; Ma XD; Shen M; Zhou XC; Qiu G
    Int J Antimicrob Agents; 2024 Jul; 64(1):107179. PubMed ID: 38677527
    [No Abstract]   [Full Text] [Related]  

  • 10. Incidence and predictors of acute kidney injury associated with intravenous polymyxin B therapy.
    Kubin CJ; Ellman TM; Phadke V; Haynes LJ; Calfee DP; Yin MT
    J Infect; 2012 Jul; 65(1):80-7. PubMed ID: 22326553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In reply to the Letter to Editor regarding "Acute kidney injury associated with colistin sulfate vs. polymyxin B sulfate therapy: A real-world, retrospective cohort study".
    Zhang Y; Ye Z; Jiang S
    Int J Antimicrob Agents; 2024 Jul; 64(1):107178. PubMed ID: 38677528
    [No Abstract]   [Full Text] [Related]  

  • 12. Risk factors for polymyxin B-associated acute kidney injury.
    Chang K; Wang H; Zhao J; Yang X; Wu B; Sun W; Huang M; Cheng Z; Chen H; Song Y; Chen P; Chen X; Gan X; Ma W; Xing L; Wang Y; Cao B
    Int J Infect Dis; 2022 Apr; 117():37-44. PubMed ID: 35108608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe Infusion-Related Adverse Events and Renal Failure in Patients Receiving High-Dose Intravenous Polymyxin B.
    John JF; Falci DR; Rigatto MH; Oliveira RD; Kremer TG; Zavascki AP
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29038262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Higher incidence of acute kidney injury with intravenous colistimethate sodium compared with polymyxin B in critically ill patients at a tertiary care medical center.
    Akajagbor DS; Wilson SL; Shere-Wolfe KD; Dakum P; Charurat ME; Gilliam BL
    Clin Infect Dis; 2013 Nov; 57(9):1300-3. PubMed ID: 23840000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of risk factors of polymyxin B-associated acute kidney injury in intensive care unit patients with severe infection].
    Wang Y; Chen X; Guo X; Cao K; Zhu Z; Zhang B; Liang P; Yu W
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Jun; 32(6):716-720. PubMed ID: 32684219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attributable Risk and Time Course of Colistin-Associated Acute Kidney Injury.
    Miano TA; Lautenbach E; Wilson FP; Guo W; Borovskiy Y; Hennessy S
    Clin J Am Soc Nephrol; 2018 Apr; 13(4):542-550. PubMed ID: 29545383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of Acute Kidney Injury in Intermittent Versus Continuous Infusion of Polymyxin B in Hospitalized Patients.
    Alvarado Reyes Y; Cruz R; Gonzalez J; Perez Y; Wolowich WR
    Ann Pharmacother; 2019 Sep; 53(9):886-893. PubMed ID: 30971094
    [No Abstract]   [Full Text] [Related]  

  • 18. Battle of polymyxin induced nephrotoxicity: Polymyxin B versus colistin.
    Ballı FN; Ekinci PB; Kurtaran M; Kara E; Dizman GT; Sönmezer MÇ; Hayran M; Demirkan K; Metan G
    Int J Antimicrob Agents; 2024 Feb; 63(2):107035. PubMed ID: 37979889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymyxin-B and vancomycin-associated acute kidney injury in critically ill patients.
    Soares DS; Reis ADF; Silva Junior GBD; Leite TT; Parente Filho SLA; Rocha CVO; Daher EF
    Pathog Glob Health; 2017 May; 111(3):137-142. PubMed ID: 28353411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Risk factors for acute kidney injury in patients treated with polymyxin B experience from 139 cases at a tertiary university hospital in Colombia].
    Osorio J; Barreto J; Samboni CF; Cándelo LA; Álvarez LC; Benavidez S; Téllez RP; Santofimio D; Ramos JA; Gómez CA
    Rev Chilena Infectol; 2017 Feb; 34(1):7-13. PubMed ID: 28394975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.